Clare A. Whicher

Terminus Terrace
Southampton, ENG SO143DT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study.

Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study.

Journal: BMC psychiatry

Published: July 29, 2021

The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomized, double-blind, placebo-controlled trial.

The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomized, double-blind, placebo-controlled trial.

Journal: Diabetes, obesity & metabolism

Published: December 04, 2020

Diabetes in the UK: 2019.

Diabetes in the UK: 2019.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: January 03, 2020

Innovation in diabetes: insulin, research priorities and new recruitment.

Innovation in diabetes: insulin, research priorities and new recruitment.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: November 14, 2019

The 8th meeting of North European Young Diabetologists.

The 8th meeting of North European Young Diabetologists.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: September 16, 2019

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial.

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial.

Journal: Trials

Published: February 19, 2019

Language matters: a UK perspective.

Language matters: a UK perspective.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: August 10, 2018

Language matters. Addressing the use of language in the care of people with diabetes: position statement of the English Advisory Group.

Language matters. Addressing the use of language in the care of people with diabetes: position statement of the English Advisory Group.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: June 07, 2018

Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation.

Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation.

Journal: European journal of endocrinology

Published: January 09, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026